46 Three year study of adefovir dipivoxil (ADV) demonstrates sustained efficacy in presumed precore mutant chronic hepatitis B (CHB) patients in a long term safety and efficacy study (LTSES)
- 1 January 2004
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: